The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
NCT00336466
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Cardiac Surgery
Brain Injury
Interventions
DRUG:
Human recombinant erythropoietin
Sponsor
University of Calgary
Collaborators
[object Object]
[object Object]